СТРУКТУРА БАКТЕРИАЛЬНЫХ ВОЗБУДИТЕЛЕЙ ВНЕБОЛЬНИЧНОЙ ПНЕВМОНИИ В МНОГОПРОФИЛЬНЫХ СТАЦИОНАРАХ СМОЛЕНСКА

Структура бактериальных возбудителей внебольничной пневмонии в многопрофильных стационарах Смоленска

1. Государственный доклад о состоянии здоровья населения Российской Федерации в 2003 году.М.: ГЭОТАРМедиа; 2003.

2. Внебольничная пневмония у взрослых: практические.рекомендации по диагностике, лечению и профилактике у взрослых / Чучалин А.Г., Синопальников А.И.,Страчунский Л.С. и др. М.: Атмосфера; 2006.

3. Charles P.G.P., Whitby M., Fuller A.J. et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin. Infect. Dis. 2008; 46: 1513–1521.

4. Mandell L.A., Wunderink R.G., Anzueto A. et al. IDSA / ATS Consensus Guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44(Suppl. 2): S27–S72.

5. Lim W.S., Baudouin S.V., George R.C. et al. BTS guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009; 64: iii1–iii55.

6. Зубков М.Н. Сбор, транспортировка биологического материала и трактовка результатов микробиологических исследований. Клин. микробиол. и антимикроб.химиотер. 2004; 6 (2): 143–154.

7. Середкина М.А., Кречикова О.И., Сухорукова М.В. Микробиологическое исследование аутопсийного материала и интерпретация его результатов. Клин. Микробиол. и антимикроб. химиотер. 2000; 2 (2): 79–85.

8. Зубков М.Н.Микробиологическая диагностика при легочных заболеваниях. В кн.: Чучалин А.Г. (ред.). Респираторная медицина. М.: ГЭОТАР Медиа; 2007; т. 1:238–252.

9. Зубков М.Н., Стецюк О.У., Козлов Р.С., Страчунский Л.С.Этиология и микробиологическая диагностика внебольничных пневмоний. В кн.: Чучалин А.Г., Синопальников А.И., Чернеховская Н.Е. (ред.). Пневмония. М.: Экономика и информатика; 2002. 9–48.

10. Available from: http://www.interlabservice.ru/catalog/reagents

11. Available from: http://www.savyondiagnostics.com

12. Available from: http://www.vircell.com

13. Fine M.J., Smith M.A., Carson C.A. et al. Prognosis and outcomes of patients with community-acquired pneumonia.A meta-analysis. J.A.M.A. 1996; 275:134–141.

14. Marston B.J., Plouffe J.F., File T.M.Jr. et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population based active surveillance study in Ohio. Arch. Intern. Med. 1997; 157: 1709–1718.

15. Park D.R., Sherbin V.L., Goodman M.S. et al. The aetiology of community-acquired pneumonia at an urban public hospital: influence of immunodeficiency virus infection and initial severity of illness. J. Infect. Dis. 2001; 84: 268–277.

16. Miyashita N., Fukano H., Niki Y. et al. Aetiology of community-acquired pneumonia requiring hospitalization in Japan. Chest 2001; 119: 1295–1296.

17. Ruiz%Gonzalez A., Falguera M., Nogues A. et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown aetiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am. J. Med. 1999; 106: 385–390.

18. Luna C.M., Famiglietti A., Absi R. et al. Community-acquired pneumonia: aetiology. epidemiology. and outcome at a teaching hospital in Argentina. Chest 2000; 118:1344–1354.

19. Scott J.A., Hall A.J., Muyodi C. et al. Aetiology, outcome,and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 2000; 355: 1225–1230.

20. Lim W.S., MacFarlane J.T., Boswell T.C.J. et al. Study of community acquired pneumonia aetiology in adults admitted to hospital: implications for management guidelines.Thorax 2001; 56: 296–301.

21. Wattanathum A., Chaoprasong C., Nunthapisud P. et al.Community-acquired pneumonia in southeast Asia. Chest 2003; 123: 1512–1519.

22. Davidson R.J., Macdonald K.S. Laboratory diagnosis of community-acquided pneumonia. In: Marrie T.J., ed.Community-acquired pneumonia. New York: Kluwer Academic / Plenum Publishers; 2001. 35–43.

23. Afshar N., Tabas J., Afshar K. et al. Blood cultures for com-munity-acquired pneumonia: are they worthy of two quality measures? A systematic review. J. Hosp. Med. 2009; 4:112–123.

24. Rello J., Quintana E., Aussina V. et al. A three-year study of severe community acquired pneumonia with emphasis on outcome. Chest 1993; 103: 232–235.

25. Almirall J., Mesalles E., Klamburg J. et al. Prognostic factors of pneumonia requiring admission to the intensive care unit.Chest 1995; 107: 511–516.

26. Pachon J., Prados M.D., Capote F. et al. Severe community-acquired pneumonia. Etiology, prognosis, and treatment.Am. Rev. Respir. Dis. 1990; 142: 369–373.

27. Ortqvist A., Sterner G., Nilsson J.A. Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand. J. Infect. Dis. 1985;17: 377–386.

28. Богданов М.В., Черненькая Т.В. Влияние "антибиотического" анамнеза на этиологию внебольничных пневмоний. Клин. фармакол. и тер. 1999; 8: 20–22.

29. Musher D.M., Montoya R., Wanahita A. Diagnostic value of microscopic examination of Gram stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 2004; 39: 165–169.

30. Рачина С.А., Иванчик Н.В., Кречикова О.И. и др. Влияние предшествующей антибактериальной терапии на результативность микробиологических исследований при внебольничной пневмонии. Клин. микробиол. и антимикроб. химиотер. 2007; 9 (Прил. 1): 35–36.

31. Glerant J.C., Hellmuth D., Schmit J.L. et al. Utility of blood cultures in community-acquired pneumonia requiring hospitalization: influence of antibiotic treatment before admission. Respir. Med. 1999; 93: 208–212.

32. Genne D., Siegrist H.H., Lienhard R. Enhancing the etiologic diagnosis of community acquired pneumonia in adults using the urinary antigen assay (Binax NOW). Intern. J.Infect. Dis. 2006; 10: 124-128.

33. Gutierrez F., Rodriequez J.C., Ayelo A. et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin. Infect. Dis. 2003; 36: 286–292.

34. Moellering R.C.Jr. The continuing challenge of lower respiratory tract infections. Clin. Infect. Dis. 2004; 38 (Suppl. 4):S319– S321.

35. Jennings L.C., Anderson T.P., Beynon K.A. et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63: 42–48.

36. Reechaipichitkul W., Lulitanond V., Sawanyawisuth K. et al.Etiologies and treatment outcomes for out-patients with community-acquired pneumonia (CAP) at Srinagarid Hospital. Khon Kaen. Tailand. South. Asian J. Trop. Med.Publ. Hlth 2005; 36: 1261–1267.

37. Yen M.%Y., Hu B.%S., Chen Y.%S. et al. A prospective etiologic study of community acquired pneumonia in Taiwan.J. Formos. Med. Assoc. 2005; 104: 724–730.

38. Saito A., Kohno S., Matsushima T. et al. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J. Infect. Chemother. 2006; 12: 63–69.

39. Guchev I.A., Yu V.L., Sinopalnikov A.I. et al.Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pmeumoniae: an innovative approach to target therapy. Clin. Infect. Dis. 2005; 40:1608–1615.

40. Gutierrez F., Masia M., Rodriguez J.C. et al. Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21stcentury: a prospective study on the Mediterranean coast of Spain. Clin. Microbiol. Infect. 2005; 11:788–800.

41. Torres A., Dorca J., Zalacain R. et al. Community-acquired pneumonia in chronic obstructive pulmonary disease:A Spanish multicenter study. Am. J. Respir. Crit. Care Med.1996; 154: 1456–1461.

42. Leesik H., Ani U., Juhani A. et al. Microbial pathogens of adult community acquired pneumonia in Southern Estonia. Medicina (Kaunas) 2006; 42: 384–394.

43. Синопальников А.И., Тартаковский И.С., Миронов М.Б.Внебольнично приобретенная пневмония: этиологический диагноз. Антибиотики и химиотер. 1997; 42(10): 38–43.

44. Савинова Т.Л., Бейкин Я.Б., Шилова В.П. и др. Практический опыт лабораторной диагностики внебольничных пневмоний. Клин. микробиол. и антимикроб. химиотер. 2009; 11 (1): 79–85.

45. Wu C.L., Chan M.C., Chang G.C. et al. Eliology and cytokine expression in patients requiring mechanical ventilation due to severe community acquired pneumonia.J. Formos. Med. Assoc. 2006; 105: 49–55.

46. Paganin F., Lilienthal F., Bourdin A. et al. Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur. Respir. J. 2004; 24: 779–785.

47. von Baum H., Welte T., Marre R. et al. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis. incidence and predictors. The German Competence Network for Community-acquired pneumonia(CAPNETZ). Eur. Respir. J. 2010; 35 (3): 598–605.

48. Практические рекомендации по диагностике и лечению легионеллезной инфекции, вызванной Legionella pneumophila серогруппы 1: Пособие для врачей / Чучалин А.Г., Синопальников А.И., Тартаковский И.С. и др.М.; 2009.

49. Diederen B.M.W. Legionella spp. and Legionnaires' disease.J. Infect. 2007; xx: 1–12.

50. von Baum H., Welte T., Marre R. et al. Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community acquired pneumonia (CAPNETZ). BMC Infect. Dis. 2009; 9: 62.

51. Miyashita N., Ouchi K., Kawasaki K. et al. Mycoplasma pneumoniae pneumonia in the elderly. Med. Sci. Monit.2008; 14 (8): CR387– CR391.

52. Ausina V., Coll P., Sambeat M. et al. Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 1988; 7:342–347.

53. Gray G.C., Duffi L. B., Paver R.J. et al. Mycoplasma pneumoniae: a frequent cause of pneumonia among U.S.Marines in southern California. Milit. Med. 1997; 162:524–526.

54. Hyde T.B., Gilbert M., Schwartz S.B. et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J. Infect. Dis. 2001; 187: 907–912.

55. Wellinghausen N., Straube E., Freidank H. et al. Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int. J. Med. Microbiol. 2006; 296:485–491.

56. Arnold F.W., Summersgill J.T., Lajoie A.S. et al. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175:1086–1093.

57. Macfarlane J., Holmes W.,Gard P. et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56:109–114.

58. Schneeberger P.M., Dorigo%Zetsma J.W., van der Zee A. et al.Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand. J. Infect.Dis. 2004; 36: 269–273.

59. Kumar S., Hammerschlag M.R. acute respiratory infection due to chlamydia pneumoniae: current status of diagnostic methods. Clin. Infect. Dis. 2007; 44: 568–576.

60. Gupta S.K., Imperiale T.F., Sarosi G.A. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest 2001; 120 (4): 1064–1071.

61. Fernandez%Sabe N., Roson B., Carratala J. et al. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin. Infect. Dis. 2003; 37: 483–489.

62. Yu V.L., Stout J.E. Community acquired Legionnaires disease: implications for underdiagnosis and laboratory testing.Clin. Infect. Dis. 2008; 46: 1365–1367.

63. de Roux A., Ewig S., Garcia E. et al. Mixed community-acquired pneumonia in hospitalized patients. Eur. Respir. J.2006; 27: 795–800.

64. Beersema M.F., Dirven K., van Dam A.P. et al. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumonia-specific immunoglobulin G (IgG)

65. and IgM antibodies, with PCR used as the "gold standard".J. Clin. Microbiol. 2005; 43: 2277–2285.

66. Тартаковский И.С., Синопальников А.И. Легионеллез:роль в инфекционной патологии человека. Клин. микробиол. и антимикроб. химиотер. 2001; 3: 4–16.

67. Jespersen S., Sogard O.S., Fine M.J. et al. The relationship between diagnostic tests and case characteristics in Legionnaires' disease. Scand. J. Infect. Dis. 2009; 8: 1–8.